Abstract
We have examined the impact of methylprednisolone acetate (MPA) on survival of F344 rats that were bearing avian sarcoma virus (ASV)-induced gliomas and that were treated optimally with radiotherapy. Toxicity of MPA (dose range of 0.2–5.0 mg/kg × 7 over 3 weeks) was first established in non-tumor bearing rats as assessed by their relative failure to gain weight. Doses of 2.0 or 5.0 mg/kg x 7 caused animals to be 21.8 or 43.9%, respectively, underweight compared with vehicle controls. In rats bearing ASV induced gliomas, treatment with 3 000 cGY (nine fractions over a 3-week period) alone or with 0.2 or 1.0 mg MPA/kg (× 6 during the 3-week radiotherapy course) produced a significantly prolonged survival compared with that of untreated, tumor bearing rats. However, MPA did not enhance survival when given concurrently with radiotherapy; indeed, at the higher of these two doses, median survival of tumor-bearers was slightly less than with radiotherapy alone. This trend towards interference with the beneficial effects of radiotherapy was more pronounced with the highest dose of MPA studied, 5.0 mg/kg body weight × 6. These animals had a median survival time that was significantly less than that of tumor-bearers receiving radiotherapy alone, but not significantly different from untreated rats with gliomas. The possible significance of these observations is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Miller, JD, Skalar, R, Ward, JD, Young, HF, Adams, WE, Vries, JK, Becker, DP: Methylprednisolone treatment in patients with brain tumors. Neurosurgery 1:114–117, 1977.
Mealey, J, Chen, TT, Schnz, GP: Effects of dexamethasone and methylprednisolone in cell cultures of human glioblastoma. J Neurosurg 34:324–334, 1971.
Copeland, DD, Vogel, FS, Bigner, DD: The induction of intracranial neoplasms by the inoculation of avian sarcoma virus in perinatal and adult rats. J Neuropathol Exp Neurol 34:340–358, 1975.
Gehan, EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203–223, 1965.
Steinbok, P, Mahaley, MS Jr, U R, Varia, MA, Lipper, S, Mahaley, J, Dalzell, JG, Bigner, DD: Treatment of autochthonous rat brain tumors with fractionated radiotherapy: the effects of graded radiation doses and of combined therapy with BCNU or steroids. J Neurosurg 53:68–72, 1980.
Green, SB, Byar, DP, Walker, MD, Pistenma, DA, Alexander E Jr, Batzdorf, U, Brooks, WH, Hunt, WE, Mealey, J Jr, Odom, GL, Paoletti, P, Ransohoff, J II, Robertson, JT, Selker RG, Shapiro, WR, Smith, KR Jr, Wilson, CB, Strike, TA: Comparisons of carmustine, procarbazine, and high dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67:121–132, 1982.
Arenander, A, De Vellis, J: Glial released proteins in clonal cultures and their modulation by hydrocortisone. Brain Res 200:401–419, 1980.
Pishak, MR, Phillips, AT: Glucocorticoid stimulation of glutamine synthetase production in cultured rat glioma cells. J Neurochem 34(4):866–872, 1980.
Vaughan, PFT, Frame, MC, Freshney, RI: The effect of dexamethasone, isoprenaline, and drugs which induce differentiation or have anticancer properties on glutamine synthesis and adenyl cyclase in cell cultures from human brain. Trans Biochem Soc 11:216–217, 1983.
Wright, RL, Shaumba, B, Keller, J: The effect of glucocorticoids on growth and metabolism of experimental glial tumors. J Neurosurg 30:140–145, 1969.
Grasso, RJ, Johnson, CE, Boler, RK, Moore, NA: Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis-(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures. Cancer Res 37:585–594, 1977.
Renaudin, J, Fewer, D, Wilson, CB, Boldrey, EB, Calogero J, Enot, KJ: Dose dependency of Decadron in patients with partially excised brain tumors. J Neurosurg 39:302–305, 1973.
Selker RG, Moore P, Odachowski S: Corticosteroid therapy in the management of gliomas. In: Paoletti P, Walker MD, Butti G, Knerich R (eds): Multidisciplinary Aspects of Brain Tumor Therapy. Elsevier/North-Holland Biomedical Press, 1979, pp 143–153.
Sherbet, GV, Lakshmi, MS, Haddad, SK: Does dexamethasone inhibit the growth of human gliomas? J Neurosurg 47:864–870, 1977.
Guner, M, Freshney, RI, Morgan, D, Freshney, MG, Thomas DGT, Graham, DI: Effects of dexamethasone and betamethasone on in vitro cultures from human astrocytoma. Br J Cancer 35:439–447, 1977.
Freshney, RI: Effects of glucocorticoids on glioma cells in culture. Mini review on cancer research. Expl Cell Biol 52:286–292, 1984.
Guarcy, O, Wilson, C, Barker, M, Eliason, J: Corticosteroid effect on transplantable rat glioma. Arch Neurol 24:266–269, 1971.
Shapiro, WR, Posner, JB: Corticosteroid hormones: effects in an experimental brain tumor. Arch Neurol 30:217–221, 1974.
Lieberman, A, Lebrun, Y, Glass, P, Goodgold, A, Luz, W, Wise, A, Ransohoff, J: Use of high dose corticosteroids in patients with inoperable brain tumors. J Neurol Neurosurg Psychiat 40:678–682, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Hennawi, Y., Gillespiel, G.Y., Varian, M.A. et al. Effect of methylprednisolone on radiotherapy of F344 rats with avian sarcoma virus induced gliomas. J Neuro-Oncol 4, 309–313 (1987). https://doi.org/10.1007/BF00150620
Issue Date:
DOI: https://doi.org/10.1007/BF00150620